Literature DB >> 21187788

The direct and indirect cost burden of acute coronary syndrome.

Stephen S Johnston1, Suellen Curkendall, Dinara Makenbaeva, Essy Mozaffari, Ron Goetzel, Wayne Burton, Ross Maclean.   

Abstract

OBJECTIVE: Quantify the incremental health care costs and workplace absence and short-term disability costs, to payers and employers, of patients hospitalized for acute coronary syndrome (ACS).
METHODS: Retrospective study using medical insurance claims for the years 2002 to 2007. Patients were aged 18 to 64 years and hospitalized for ACS between January 1, 2003, and December 31, 2006; comparison patients without evidence of coronary artery disease were also selected. The incremental impact of ACS was estimated using weighted regression.
RESULTS: 30,200 ACS patients were selected. Incremental annual direct costs of ACS were $40,671 (P < 0.001). For the indirect cost sub-analyses, incremental short-term disability costs of ACS were $999 (P < 0.001) and incremental absence costs were insignificant (P = 0.314) but from a small sample (N = 416).
CONCLUSIONS: Patients with ACS impose a substantial direct cost burden on employers and payers and a substantial indirect cost burden on employers. Acute coronary syndrome is more costly to employers and payers than other health conditions that are common among employed persons. Rehospitalizations after the initial hospitalization are common and represent a large portion of the cost.

Entities:  

Mesh:

Year:  2011        PMID: 21187788     DOI: 10.1097/JOM.0b013e31820290f4

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  18 in total

1.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

2.  Depression and rehospitalization following acute myocardial infarction.

Authors:  Rebecca L Reese; Kenneth E Freedland; Brian C Steinmeyer; Michael W Rich; Justin W Rackley; Robert M Carney
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-10-18

Review 3.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

Review 4.  A call to action: responding to the future forecasting of cardiovascular disease in america.

Authors:  Robert Lee Page; Vahram Ghushchyan; Kavita Nair
Journal:  Am Health Drug Benefits       Date:  2011-09

5.  Depressive Symptoms and Perceptions of ED Care in Patients Evaluated for Acute Coronary Syndrome.

Authors:  Tara St Onge; Donald Edmondson; Emily Cea; Syed Husain; Bernard P Chang
Journal:  J Emerg Nurs       Date:  2017-05-17       Impact factor: 1.836

6.  Productivity loss and indirect costs associated with cardiovascular events and related clinical procedures.

Authors:  Xue Song; Ruben G W Quek; Shravanthi R Gandra; Katherine A Cappell; Robert Fowler; Ze Cong
Journal:  BMC Health Serv Res       Date:  2015-06-25       Impact factor: 2.655

7.  Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults.

Authors:  Daniel Polsky; Machaon Bonafede; Jose A Suaya
Journal:  BMC Health Serv Res       Date:  2012-10-31       Impact factor: 2.655

8.  Clinical and economic outcomes among hospitalized patients with acute coronary syndrome: an analysis of a national representative Medicare population.

Authors:  Shih-Yin Chen; Concetta Crivera; Michael Stokes; Luke Boulanger; Jeffrey Schein
Journal:  Clinicoecon Outcomes Res       Date:  2013-05-01

9.  Economic burden of acute coronary syndrome in South Korea: a national survey.

Authors:  Jinhyun Kim; Eunhee Lee; Taejin Lee; Aeree Sohn
Journal:  BMC Cardiovasc Disord       Date:  2013-08-08       Impact factor: 2.298

10.  Prognostic value of heart rate turbulence for risk assessment in patients with unstable angina and non-ST elevation myocardial infarction.

Authors:  Patricia R E Harris; Phyllis K Stein; Gordon L Fung; Barbara J Drew
Journal:  Vasc Health Risk Manag       Date:  2013-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.